Answers are grounded in this paper and cite their sources.
In vitro evaluation demonstrates high cytotoxicity and tumor cell selectivity of bimetallic ruthenium(II)-gold(I) complexes, highlighting their therapeutic potential as targeted anticancer agents.
demonstrating the best overall performance, combining strong cytostatic properties with high selectivity toward cancerous cells. These findings highlight the structural, electronic, and biological relationships of the complexes, underlining their potential as anticancer agents.
No takes yet. Share an insight, caveat, or question.
Blignaut et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: